Procedural complication and long term outcomes after alcohol septal ablation in patients with obstructive hypertrophic cardiomyopathy: data from China

被引:14
|
作者
An, Shuo-yan [1 ,2 ]
Yang, Yin-jian [1 ,2 ]
Hang, Fei [1 ,2 ]
Wang, Zhi-min [2 ,3 ]
Fan, Chao-mei [1 ,2 ]
机构
[1] Chinese Acad Med Sci, Key Lab Clin Trial Res Cardiovasc Drugs, Minist Hlth, Fuwai Hosp,Natl Ctr Cardiovasc Dis, Beijing, Peoples R China
[2] Peking Union Med Coll, Beijing, Peoples R China
[3] Chinese Acad Med Sci, Natl Ctr Cardiovasc Dis, Fuwai Hosp, Dept Ultrasound, Beijing, Peoples R China
来源
SCIENTIFIC REPORTS | 2017年 / 7卷
关键词
TASK-FORCE; FOLLOW-UP; MYECTOMY; SURVIVAL; METAANALYSIS; GUIDELINE; DIAGNOSIS; DEATH; YOUNG;
D O I
10.1038/s41598-017-10144-0
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
Data on procedural complications and long term survival after alcohol septal ablation (ASA) in Chinese patients with obstructive hypertrophic cardiomyopathy (HOCM) are lacking. We aimed to investigate long-term survival of HOCM patients after ASA and compared to the non-obstructive hypertrophic cardiomyopathy(NOHCM). A total of 233 patients with HOCM and a peak pressure gradient of >= 50 mm Hg at rest or with provocation were consecutively enrolled from Fuwai Hospital in China between 2000 and 2012. Another 297 patients without left ventricular outflow tract obstruction were regarded as control group. Periprocedural mortality of ASA were low (0.89%). Periprocedural lethal ventricular arrhythmia occurred in 9 patients (4.0%). Alcohol volume (RR 1.44, 95% CI: 1.03-2.03, P = 0.034) and age <= 40 years old (RR 4.63, 95% CI: 1.07-20.0, P = 0.040) were independent predictors for periprocedural lethal ventricular arrhythmia. The 10-year overall survival was 94.6% in the ASA group, similar with 92.9% in the NOHCM group (P = 0.930). In conclusion, periprocedural mortality and complications were rare in ASA. Long term survival after ASA were satisfactory and comparable to NOHCM. Patients under 40 years old should be more cautious undergoing ASA, for these patients were more likely to endure lethal ventricular arrhythmia during periprocedural period of ASA.
引用
收藏
页数:7
相关论文
共 50 条
  • [41] Predictors of outcome after alcohol septal ablation therapy in patients with hypertrophic obstructive cardiomyopathy
    Chang, SM
    Lakkis, NM
    Franklin, J
    Spencer, WH
    Nagueh, SF
    CIRCULATION, 2004, 109 (07) : 824 - 827
  • [42] Reduction in mitral regurgitation after alcohol septal ablation in patients with hypertrophic obstructive cardiomyopathy
    Crawford, FA
    Nielsen, C
    Fernandes, V
    Frankis, M
    Spencer, WH
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2003, 41 (06) : 146A - 146A
  • [43] Long-Term Follow-Up Post Alcohol Septal Ablation in Patients With Obstructive Hypertrophic Cardiomyopathy
    Leung, Dickson
    Cheung, Po Kee
    Tyrrell, Benjamin
    Tan, Joon Heng
    Dorsch, Micha
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2022, 80 (12) : B144 - B144
  • [44] Percutaneous alcohol septal ablation for hypertrophic obstructive cardiomyopathy: Technical review and long-term clinical and echocardiographic outcomes
    Leal, Silvio
    Galeote, Guillermo
    Jimenez-Valero, Santiago
    Sanchez-Recalde, Angel
    Salinas, Pablo
    Saez Ruiz, Alejandro
    Calvo Orbe, Luis
    Dominguez, Francisco
    Moreno, Raul
    Luis Lopez-Sendon, Jose
    REVISTA PORTUGUESA DE CARDIOLOGIA, 2012, 31 (05) : 363 - 371
  • [45] Update on alcohol septal ablation for hypertrophic obstructive cardiomyopathy
    Veselka, Josef
    Polakova, Eva
    Bonaventura, Jiri
    KARDIOLOGIA POLSKA, 2019, 77 (02) : 160 - 161
  • [46] Outcome of alcohol septal ablation for obstructive hypertrophic cardiomyopathy
    Sorajja, Paul
    Valeti, Uma
    Nishimura, Rick A.
    Ommen, Steve R.
    Rihal, Charanjit S.
    Gersh, Bernard J.
    Hodge, David O.
    Schaff, Hartzell V.
    Holmes, David R., Jr.
    CIRCULATION, 2008, 118 (02) : 131 - 139
  • [47] Alcohol Septal Ablation for Hypertrophic Obstructive Cardiomyopathy: Is it Safe?
    Veselka, Josef
    CATHETERIZATION AND CARDIOVASCULAR INTERVENTIONS, 2009, 74 (03) : 520 - 521
  • [48] Mortality After Alcohol Septal Ablation vs. Septal Myectomy in Patients With Obstructive Hypertrophic Cardiomyopathy
    Yasuda, Risako
    Osawa, Itsuki
    Goto, Tadahiro
    Hasegawa, Kohei
    Fifer, Michael A.
    Tower-Rader, Albree
    Reilly, Muredach P.
    Maurer, Mathew S.
    Zhao, Yanling
    Takayama, Hiroo
    Shimada, Yuichi J.
    CIRCULATION REPORTS, 2024, 6 (03) : 74 - 79
  • [49] Alcohol Septal Ablation or Mavacamten for Obstructive Hypertrophic Cardiomyopathy
    Scholtz, Smita
    Rudolph, Volker
    Reil, Jan-Christian
    JOURNAL OF CLINICAL MEDICINE, 2023, 12 (20)
  • [50] Alcohol dose in septal ablation for hypertrophic obstructive cardiomyopathy
    Veselka, Josef
    Faber, Lothar
    Liebregts, Max
    Cooper, Robert
    Januska, Jaroslav
    Kashtanov, Maksim
    Dabrowski, Maciej
    Hansen, Peter Riis
    Seggewiss, Hubert
    Bonaventura, Jiri
    Polakova, Eva
    Hansvenclova, Eva
    Bundgaard, Henning
    ten Berg, Jurrien
    Stables, Rodney Hilton
    Jarkovsky, Jiri
    Jensen, Morten Kvistholm
    INTERNATIONAL JOURNAL OF CARDIOLOGY, 2021, 333 : 127 - 132